These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8516549)

  • 41. [Neuron specific enolase-producing IgD multiple myeloma with high serum amylase activity].
    Nakajima T; Noguchi T; Kumahara Y; Sugihara A; Yamazaki T; Iwasaki T; Hamano T; Kakishita E
    Rinsho Ketsueki; 1995 Apr; 36(4):359-64. PubMed ID: 7540226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathologic quiz case: an 81-year-old woman with compression fracture and renal failure. Multiple myeloma with a monoclonal serum IgD lambda immunoglobulin.
    Poulos CK; Ryder KW
    Arch Pathol Lab Med; 2003 Oct; 127(10):1383-4. PubMed ID: 14521448
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunoglobulin D multiple myeloma in our hospital--a rare occurrence.
    Tan LK; Suri R; Lim HL; Ong SK
    Singapore Med J; 2000 Oct; 41(10):500-3. PubMed ID: 11281443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrophoretic analysis of microheterogeneity of paraproteins in a patient with IgD myeloma.
    Stulík J; Kovárová H; Tichý M; Urban P
    Neoplasma; 1995; 42(3):105-8. PubMed ID: 7637817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunochemical evaluation of monoclonal gammopathies: heavy chain to light chain ratio is of little practical value for detecting IgD myelomas and free light chains.
    Bianchi P; MacNamara E; Bergami MR; Gasparro C; Jones R; Whicher JT; Bienvenu J; Aguzzi F
    Clin Chem; 1992 Feb; 38(2):317-9. PubMed ID: 1541025
    [No Abstract]   [Full Text] [Related]  

  • 46. Can leptomeningeal myelomatosis be predicted in patients with IgD multiple myeloma?
    Velasco R; Petit J; Llatjós R; Juan A; Bruna J
    J Clin Neurosci; 2010 Aug; 17(8):1071-2. PubMed ID: 20488713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [IgD paraproteinemia].
    Shinkov D; Shereva T; Tolev V; Zhivkov I
    Vutr Boles; 1976; 15(4):92-6. PubMed ID: 827125
    [No Abstract]   [Full Text] [Related]  

  • 49. [Light chain escape followed by leukemic transformation in a patient with IgD myeloma].
    Hatsuse M; Fuchida S; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2015 Jan; 56(1):48-50. PubMed ID: 25745970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Second neoplasm in a patient diagnosed with IgD myeloma. Presentation of a case and review of the literature].
    González Silva M
    Sangre (Barc); 1993 Feb; 38(1):47-9. PubMed ID: 8385807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgD-kappa myeloma: an unusual case.
    Tharp AM; Woodruff RD; Shihabi ZK
    Ann Clin Lab Sci; 2003; 33(1):97-100. PubMed ID: 12661904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An unusual case of myeloma. Non-secretory IgD-kappa myeloma with de-differentiation of kappa myeloma evolving from solitary plasmocytoma.
    Nelis GF
    Acta Med Scand; 1982; 211(1-2):141-4. PubMed ID: 6803520
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unusual myelomas: a review of IgD and IgE variants.
    Pandey S; Kyle RA
    Oncology (Williston Park); 2013 Aug; 27(8):798-803. PubMed ID: 24133829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoglobulin D lambda multiple myeloma and amyloidosis with predominant soft tissue involvement.
    Bahat G; Erten N; Saka B; Uzun S; Onur I; Kalayoglu-Besisik S; Buyukbabani N
    Amyloid; 2007 Dec; 14(4):305-8. PubMed ID: 17968692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Amyloidosis associated with IGD (lambda) myeloma in a Hansen's disease patient].
    Feyeux C; Verola O; Bakir R; Rouffy J
    Ann Dermatol Venereol; 1983; 110(9):717-8. PubMed ID: 6419662
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
    Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
    Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoglobulin D multiple myeloma.
    Lin TL; Shih LY; Dunn P; Wang PN; Wu JH; Kao MC
    Chang Gung Med J; 2000 Aug; 23(8):451-7. PubMed ID: 11039246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of IgD-lambda myeloma.
    Jákó J; Virágh S; Brooser G; Dóbiás G; Domán J; Ottó ; Riskó Z; Szemere P
    Haematologia (Budap); 1975; 9(3-4):261-78. PubMed ID: 820613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.